DNA damage repair defects as a new class of endocrine treatment resistance driver
DNA damage repair defects as a new class of endocrine treatment resistance driver |
https://doi.org/10.18632/oncotarget.26363
Meenakshi Anurag,
Matthew J. Ellis,
and Svasti Haricharan
|
36252-36253 |
Oncolytic virotherapy – in vivo veritas
Oncolytic virotherapy – in vivo veritas |
https://doi.org/10.18632/oncotarget.26364
Iris Kemler,
Claudia Neuhauser,
and David Dingli
|
36254-36255 |
Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway
Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway |
https://doi.org/10.18632/oncotarget.26332
Janine Wörthmüller,
Walter Blum,
Laszlo Pecze,
Valérie Salicio,
and Beat Schwaller
|
36256-36272 |
The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling
The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling |
https://doi.org/10.18632/oncotarget.26345
Michelle Faria,
Peter Shepherd,
Yinghong Pan,
Sujash S. Chatterjee,
Nora Navone,
Jan-Åke Gustafsson,
and Anders Strom
|
36273-36288 |
Cytotoxic phenanthroline derivatives alter metallostasis and redox homeostasis in neuroblastoma cells
Cytotoxic phenanthroline derivatives alter metallostasis and redox homeostasis in neuroblastoma cells |
https://doi.org/10.18632/oncotarget.26346
Irina Naletova,
Cristina Satriano,
Alessandra Curci,
Nicola Margiotta,
Giovanni Natile,
Giuseppe Arena,
Diego La Mendola,
Vincenzo Giuseppe Nicoletti,
and Enrico Rizzarelli
|
36289-36316 |
Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer
Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer |
https://doi.org/10.18632/oncotarget.26347
Hiromasa Kuroda,
Seiji Mabuchi,
Eriko Yokoi,
Naoko Komura,
Katsumi Kozasa,
Yuri Matsumoto,
Mahiru Kawano,
Ryoko Takahashi,
Tomoyuki Sasano,
Kotaro Shimura,
Michiko Kodama,
Kae Hashimoto,
Kenjiro Sawada,
Eiichi Morii,
and Tadashi Kimura
|
36317-36330 |
Antitumor properties of Salvianolic acid B against triple-negative and hormone receptor-positive breast cancer cells via ceramide-mediated apoptosis
Antitumor properties of Salvianolic acid B against triple-negative and hormone receptor-positive breast cancer cells via ceramide-mediated apoptosis |
https://doi.org/10.18632/oncotarget.26348
Wei Sha,
Yanfei Zhou,
Zhi-Qiang Ling,
Guiqin Xie,
Xiaowu Pang,
Paul Wang,
and Xinbin Gu
|
36331-36343 |
Targeted next-generation sequencing reveals recurrence-associated genomic alterations in early-stage non-small cell lung cancer
Targeted next-generation sequencing reveals recurrence-associated genomic alterations in early-stage non-small cell lung cancer |
https://doi.org/10.18632/oncotarget.26349
William C.S. Cho,
Kien Thiam Tan,
Victor W.S. Ma,
Jacky Y.C. Li,
Roger K.C. Ngan,
Wah Cheuk,
Timothy T.C. Yip,
Yi-Ting Yang,
and Shu-Jen Chen
|
36344-36357 |
The phosphorylation status of PIP5K1C at serine 448 can be predictive for invasive ductal carcinoma of the breast
The phosphorylation status of PIP5K1C at serine 448 can be predictive for invasive ductal carcinoma of the breast |
https://doi.org/10.18632/oncotarget.26357
Nisha Durand,
Sahra Borges,
Tavia Hall,
Ligia Bastea,
Heike Döppler,
Brandy H. Edenfield,
Aubrey E. Thompson,
Xochiquetzal Geiger,
and Peter Storz
|
36358-36370 |
Diagnostic performance of Gd-EOB-DTPA-enhanced MRI for evaluation of liver dysfunction: a multivariable analysis of 3T MRI sequences
Diagnostic performance of Gd-EOB-DTPA-enhanced MRI for evaluation of liver dysfunction: a multivariable analysis of 3T MRI sequences |
https://doi.org/10.18632/oncotarget.26368
Niklas Verloh,
Kirsten Utpatel,
Florian Zeman,
Claudia Fellner,
Hans J. Schlitt,
Martina Müller,
Christian Stroszczynski,
Matthias Evert,
Philipp Wiggermann,
and Michael Haimerl
|
36371-36378 |
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast |
https://doi.org/10.18632/oncotarget.26372
Maximilian Marhold,
Erwin Tomasich,
Michael Schwarz,
Simon Udovica,
Andreas Heinzel,
Paul Mayer,
Peter Horak,
Paul Perco,
and Michael Krainer
|
36379-36391 |
Water transport proteins–aquaporins (AQPs) in cancer biology
Water transport proteins–aquaporins (AQPs) in cancer biology |
https://doi.org/10.18632/oncotarget.26351
Salah Dajani,
Anand Saripalli,
and Neelam Sharma-Walia
|
36392-36405 |
Correction: Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis
Correction: Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis |
https://doi.org/10.18632/oncotarget.26394
Zhun Wang,
Shuanghe Peng,
Ning Jiang,
Aixiang Wang,
Shuguang Liu,
Hui Xie,
Linpei Guo,
Qiliang Cai,
and Yuanjie Niu
|
36406-36406 |